查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1697961

全球精神病数位生物标记市场：市场规模、占有率、趋势、行业分析（按类型、医疗程序、最终用途和地区）、未来预测（2025-2034）

Psychiatric Digital Biomarkers Market Size, Share, Trends, Industry Analysis Report: By Type, Clinical Practice, End Use, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，全球精神病数位生物标记市场规模预计到 2034 年将达到 5,543,770 亿美元。该研究报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

精神病数位生物标记是透过数位装置收集的客观、可量化的生理和行为数据点，用于评估心理健康状况。在人工智慧、穿戴式健康技术和基于行动的心理健康监测的推动下，精神病数位生物标记市场正在经历显着扩张。忧郁症、精神分裂症和焦虑症等精神疾病的盛行率不断上升，推动了精神病数位生物标记市场的需求，临床医生和研究人员正在寻求数据驱动的即时监测工具，以实现准确诊断和个人化治疗。此外，生物感测器越来越多地融入智慧手錶、行动应用程式和人工智慧分析中，以增强远端患者监控和临床决策，也推动了市场的成长。

精神病数位生物标记产业的趋势表明，人们正在转向利用机器学习演算法来分析行为模式、音讯生物标记和生理讯号，以提高预测准确性和早期干预的能力。此外，製药和生物技术公司正在将数位生物标记纳入临床试验，以优化患者招募和治疗效果评估，从而推动精神病数位生物标记市场的扩张。此外，由于利害关係人强调遵守资料隐私和安全框架，监管发展和对数位健康技术的投资增加也在推动市场动态。

精神病数位生物标记市场的机会在于精准精神病学的发展，精准精神病学使用数位生物标记根据个别患者数据量身定制治疗策略。远距医疗和虚拟心理健康服务的日益普及也为医疗保健提供者创造了将数位监控解决方案整合到远距治疗模式中的市场机会。随着数位生物标记在监管环境中获得认可以及报销框架不断发展，多模式数据整合和人工智慧驱动的心理健康分析方面的持续技术创新将塑造精神病医疗保健的未来格局，预计市场将经历强劲增长。

精神病数位生物标记市场：概述

根据类型，穿戴式装置领域在 2024 年占据了精神病数位生物标记市场占有率的主导地位，这得益于先进的生物感测器越来越多地整合到智慧手錶、健身追踪器和穿戴式 EEG 设备中，以持续监测心理健康。

根据最终用途，医疗保健公司部门在 2024 年占据了最大的市场占有率，这得益于精神病数位生物标记在早期诊断中的应用日益增多。

由于该地区拥有先进的医疗保健基础设施，预计 2024 年北美将在精神病数位生物标记市场中占据最大的收入占有率。

由于政府支持心理健康研究的举措，预计欧洲市场在预测期内将实现最高的复合年增长率。

一些主要的全球公司包括 Biogen、Brainomix、Clario、Empatica、Huma、IXICO plc、Koneksa Health、PureTech Health PLC、Sonde Health 和 VivoSense。

目录

第一章简介

第 2 章执行摘要

第三章 分析方法

第 4 章：全球精神病数位生物标记市场洞察

  • 市场概况
  • 数位精神病生物标记的市场动态
    • 推动因素和机遇
      • 精神疾病盛行率不断上升
      • 穿戴式装置和行动医疗技术的进步
    • 阻碍因素和课题
      • 资料隐私问题
  • PESTLE 分析
  • 精神病数位生物标记市场的趋势
  • 价值链分析

第五章：全球精神病数位生物标记市场（按类型）

  • 主要发现
  • 简介
  • 穿戴式装置
  • 基于行动的应用程式
  • 感测器
  • 其他

6.全球精神病数位生物标记市场（按临床程序）

  • 主要发现
  • 简介
  • 诊断性精神病数位生物标记
  • 用于监测的精神科数位生物标记
  • 用于精神病学预测和预后的数字生物标记
  • 其他

7.全球精神病数位生物标记市场（依最终用途）

  • 主要发现
  • 简介
  • 医疗公司
  • 医疗保健提供者
  • 付款人
  • 其他

8.全球精神病数位生物标记市场（按地区）

  • 主要发现
  • 简介
    • 精神病数位生物标记市场（按地区）分析（2020-2034）
  • 北美
    • 北美，按类型划分（2020-2034 年）
    • 北美，依医疗程序分类（2020-2034 年）
    • 北美最终用途（2020-2034 年）
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲各类型（2020-2034 年）
    • 欧洲：依医疗程序分类（2020-2034 年）
    • 欧洲：依最终用途划分（2020-2034 年）
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 亚太地区按类型划分（2020-2034 年）
    • 亚太地区：依医疗程序分类（2020-2034 年）
    • 亚太地区最终用途（2020-2034）
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲
    • 中东与非洲：依类型（2020-2034 年）
    • 中东和非洲：依医疗程序划分（2020-2034 年）
    • 中东和非洲：依最终用途划分（2020-2034 年）
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲地区
  • 拉丁美洲
    • 拉丁美洲各类型（2020-2034）
    • 拉丁美洲，依医疗程序划分（2020-2034 年）
    • 拉丁美洲以最终用途划分（2020-2034 年）
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲国家

第九章 竞争格局

  • 业务扩张与收购分析
    • 业务扩展
    • 收购
  • 伙伴关係/协作/协议/揭露

第十章公司简介

  • Biogen
  • Brainomix
  • Clario
  • Empatica Inc.
  • Huma
  • IXICO plc
  • Koneksa Health
  • PureTech Health PLC
  • Sonde Health, Inc.
  • VivoSense
  • Xiamen AJK Technology Co., Ltd.
Product Code: PM5446

The global psychiatric digital biomarkers market size is expected to reach USD 5,543.77 million by 2034, according to a new study by Polaris Market Research. The report "Psychiatric Digital Biomarkers Market Size, Share, Trends, Industry Analysis Report: By Type (Wearable, Mobile-Based Applications, Sensors, and Others), Clinical Practice, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Psychiatric digital biomarkers are objective, quantifiable physiological and behavioral data points collected through digital devices to assess mental health conditions. The psychiatric digital biomarkers market is experiencing significant expansion, driven by advancements in artificial intelligence, wearable health technologies, and mobile-based mental health monitoring. The growing prevalence of psychiatric disorders, including depression, schizophrenia, and anxiety, is fueling psychiatric digital biomarkers market demand, as clinicians and researchers seek data-driven, real-time monitoring tools for accurate diagnosis and treatment personalization. The market growth is further supported by the increasing integration of biosensors in smartwatches, mobile apps, and AI-powered analytics, which enhance remote patient monitoring and clinical decision-making.

The psychiatric digital biomarkers industry trends indicate a shift toward leveraging machine learning algorithms to analyze behavioral patterns, voice biomarkers, and physiological signals, improving predictive accuracy and early intervention capabilities. Additionally, pharmaceutical and biotech companies are incorporating digital biomarkers into clinical trials, optimizing patient recruitment and therapeutic efficacy assessments, thereby driving psychiatric digital biomarkers market expansion. Regulatory advancements and increasing investments in digital health technologies are also encouraging market dynamics as stakeholders focus on ensuring compliance with data privacy and security frameworks.

The psychiatric digital biomarkers market opportunities lie in the development of precision psychiatry, where digital biomarkers are used to tailor treatment strategies based on individual patient data. The increasing adoption of telemedicine and virtual mental health services presents another market opportunity; as healthcare providers integrate digital monitoring solutions into remote care models. As digital biomarkers gain regulatory acceptance and reimbursement frameworks evolve, the market is expected to witness robust growth, with continuous innovation in multimodal data integration and AI-driven mental health analytics shaping the future landscape of psychiatric care.

Psychiatric Digital Biomarkers Market Report Highlights

In terms of type, the wearable segment dominated the psychiatric digital biomarkers market share in 2024, due to the growing integration of advanced biosensors in smartwatches, fitness trackers, and wearable EEG devices for continuous mental health monitoring.

Based on end use, the healthcare companies segment accounted for the largest market share in 2024 due to the increasing adoption of psychiatric digital biomarkers for early diagnosis.

In 2024, North America accounted for the largest share of the psychiatric digital biomarkers market revenue due to the region's advanced healthcare infrastructure.

The Europe market is expected to register the highest CAGR during the forecast period due to government initiatives supporting mental health research.

A few of the global key market players are Biogen; Brainomix; Clario; Empatica Inc.; Huma; IXICO plc; Koneksa Health; PureTech Health PLC; Sonde Health, Inc.; and VivoSense.

Polaris Market Research has segmented the psychiatric digital biomarkers market report on the basis of type, clinical practice, end use, and region:

By Type Outlook (Revenue - USD Million, 2020-2034)

  • Wearable
  • Mobile-Based Applications
  • Sensors
  • Others

By Clinical Practice Outlook (Revenue - USD Million, 2020-2034)

  • Diagnostic Psychiatric Digital Biomarkers
  • Monitoring Psychiatric Digital Biomarkers
  • Predictive and Prognostic Psychiatric Digital Biomarkers
  • Others

By End Use Outlook (Revenue - USD Million, 2020-2034)

  • Healthcare Companies
  • Healthcare Providers
  • Payers
  • Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Psychiatric Digital Biomarkers Market Insights

  • 4.1. Psychiatric Digital Biomarkers Market - Market Snapshot
  • 4.2. Psychiatric Digital Biomarkers Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Mental Health Disorders
      • 4.2.1.2. Wearable and Mobile Health Technology Advancements
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Data Privacy Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Psychiatric Digital Biomarkers Market Trends
  • 4.6. Value Chain Analysis

5. Global Psychiatric Digital Biomarkers Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • 5.3. Wearable
    • 5.3.1. Global Psychiatric Digital Biomarkers Market, by Wearable, by Region, 2020-2034 (USD Million)
  • 5.4. Mobile based Applications
    • 5.4.1. Global Psychiatric Digital Biomarkers Market, Mobile based Applications, by Region, 2020-2034 (USD Million)
  • 5.5. Sensors
    • 5.5.1. Global Psychiatric Digital Biomarkers Market, by Sensors, by Region, 2020-2034 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Psychiatric Digital Biomarkers Market, by Others, by Region, 2020-2034 (USD Million)

6. Global Psychiatric Digital Biomarkers Market, by Clinical Practice

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • 6.3. Diagnostic Psychiatric Digital Biomarkers
    • 6.3.1. Global Psychiatric Digital Biomarkers Market, by Diagnostic Psychiatric Digital Biomarkers, by Region, 2020-2034 (USD Million)
  • 6.4. Monitoring Psychiatric Digital Biomarkers
    • 6.4.1. Global Psychiatric Digital Biomarkers Market, by Monitoring Psychiatric Digital Biomarkers, by Region, 2020-2034 (USD Million)
  • 6.5. Predictive and Prognostic Psychiatric Digital Biomarkers
    • 6.5.1. Global Psychiatric Digital Biomarkers Market, by Predictive and Prognostic Psychiatric Digital Biomarkers, by Region, 2020-2034 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Psychiatric Digital Biomarkers Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Psychiatric Digital Biomarkers Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • 7.3. Healthcare companies
    • 7.3.1. Global Psychiatric Digital Biomarkers Market, by Healthcare companies, by Region, 2020-2034 (USD Million)
  • 7.4. Healthcare Providers
    • 7.4.1. Global Psychiatric Digital Biomarkers Market, by Healthcare Providers, by Region, 2020-2034 (USD Million)
  • 7.5. Payers
    • 7.5.1. Global Psychiatric Digital Biomarkers Market, by Payers, by Region, 2020-2034 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Psychiatric Digital Biomarkers Market, by Others, by Region, 2020-2034 (USD Million)

8. Global Psychiatric Digital Biomarkers Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Psychiatric Digital Biomarkers Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Psychiatric Digital Biomarkers Market - North America
    • 8.3.1. North America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
    • 8.3.2. North America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
    • 8.3.3. North America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.3.4. Psychiatric Digital Biomarkers Market - US
      • 8.3.4.1. US: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.3.4.2. US: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.3.4.3. US: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.3.5. Psychiatric Digital Biomarkers Market - Canada
      • 8.3.5.1. Canada: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • 8.4. Psychiatric Digital Biomarkers Market - Europe
    • 8.4.1. Europe: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
    • 8.4.2. Europe: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
    • 8.4.3. Europe: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.4. Psychiatric Digital Biomarkers Market - UK
      • 8.4.4.1. UK: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.5. Psychiatric Digital Biomarkers Market - France
      • 8.4.5.1. France: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.5.2. France: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.5.3. France: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.6. Psychiatric Digital Biomarkers Market - Germany
      • 8.4.6.1. Germany: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.7. Psychiatric Digital Biomarkers Market - Italy
      • 8.4.7.1. Italy: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.8. Psychiatric Digital Biomarkers Market - Spain
      • 8.4.8.1. Spain: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.9. Psychiatric Digital Biomarkers Market - Netherlands
      • 8.4.9.1. Netherlands: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.10. Psychiatric Digital Biomarkers Market - Russia
      • 8.4.10.1. Russia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.4.11. Psychiatric Digital Biomarkers Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • 8.5. Psychiatric Digital Biomarkers Market - Asia Pacific
    • 8.5.1. Asia Pacific: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.4. Psychiatric Digital Biomarkers Market - China
      • 8.5.4.1. China: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.4.2. China: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.4.3. China: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.5. Psychiatric Digital Biomarkers Market - India
      • 8.5.5.1. India: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.5.2. India: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.5.3. India: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.6. Psychiatric Digital Biomarkers Market - Malaysia
      • 8.5.6.1. Malaysia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.7. Psychiatric Digital Biomarkers Market - Japan
      • 8.5.7.1. Japan: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.8. Psychiatric Digital Biomarkers Market - Indonesia
      • 8.5.8.1. Indonesia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.9. Psychiatric Digital Biomarkers Market - South Korea
      • 8.5.9.1. South Korea: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.10. Psychiatric Digital Biomarkers Market - Australia
      • 8.5.10.1. Australia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.5.11. Psychiatric Digital Biomarkers Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • 8.6. Psychiatric Digital Biomarkers Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.6.4. Psychiatric Digital Biomarkers Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.6.5. Psychiatric Digital Biomarkers Market - UAE
      • 8.6.5.1. UAE: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.6.6. Psychiatric Digital Biomarkers Market - Israel
      • 8.6.6.1. Israel: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.6.7. Psychiatric Digital Biomarkers Market - South Africa
      • 8.6.7.1. South Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.6.8. Psychiatric Digital Biomarkers Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • 8.7. Psychiatric Digital Biomarkers Market - Latin America
    • 8.7.1. Latin America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.7.4. Psychiatric Digital Biomarkers Market - Mexico
      • 8.7.4.1. Mexico: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.7.5. Psychiatric Digital Biomarkers Market - Brazil
      • 8.7.5.1. Brazil: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.7.6. Psychiatric Digital Biomarkers Market - Argentina
      • 8.7.6.1. Argentina: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
    • 8.7.7. Psychiatric Digital Biomarkers Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Biogen
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Brainomix
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Clario
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Empatica Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Huma
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. IXICO plc
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Koneksa Health
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. PureTech Health PLC
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sonde Health, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. VivoSense
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Xiamen AJK Technology Co., Ltd.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development

List of Tables:

  • Table 1 Global Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 2 Global Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 3 Global Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 4 North America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 5 North America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 6 North America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 7 US: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 8 US: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 9 US: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 10 Canada: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 11 Canada: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 12 Canada: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 13 Europe: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 14 Europe: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 15 Europe: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 16 UK: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 17 UK: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 18 UK: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 19 France: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 20 France: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 21 France: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 22 Germany: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 23 Germany: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 24 Germany: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 25 Italy: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 26 Italy: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 27 Italy: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 28 Spain: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 29 Spain: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 30 Spain: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 31 Netherlands: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 32 Netherlands: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 33 Netherlands: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 34 Russia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 35 Russia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 36 Russia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 37 Rest of Europe: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 38 Rest of Europe: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 39 Rest of Europe: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 40 Asia Pacific: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 41 Asia Pacific: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 42 Asia Pacific: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 43 China: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 44 China: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 45 China: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 46 India: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 47 India: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 48 India: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 49 Malaysia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 50 Malaysia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 51 Malaysia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 52 Japan: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 53 Japan: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 54 Japan: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 55 Indonesia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 56 Indonesia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 57 Indonesia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 58 South Korea: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 59 South Korea: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 60 South Korea: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 61 Australia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 62 Australia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 63 Australia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 64 Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 65 Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 66 Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 67 Middle East & Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 68 Middle East & Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 69 Middle East & Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 70 Saudi Arabia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 71 Saudi Arabia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 72 Saudi Arabia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 73 UAE: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 74 UAE: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 75 UAE: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 76 Israel: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 77 Israel: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 78 Israel: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 79 South Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 80 South Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 81 South Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 82 Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 83 Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 84 Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 85 Latin America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 86 Latin America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 87 Latin America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 88 Mexico: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 89 Mexico: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 90 Mexico: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 91 Brazil: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 92 Brazil: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 93 Brazil: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 94 Argentina: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 95 Argentina: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 96 Argentina: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
  • Table 97 Rest of Latin America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  • Table 98 Rest of Latin America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  • Table 99 Rest of Latin America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Psychiatric Digital Biomarkers Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Psychiatric Digital Biomarkers Market, by Type, 2024 & 2034 (USD Million)
  • Figure 8. Market by Clinical Practice
  • Figure 9. Global Psychiatric Digital Biomarkers Market, by Clinical Practice, 2024 & 2034 (USD Million)
  • Figure 10. Market by End Use
  • Figure 11. Global Psychiatric Digital Biomarkers Market, by End Use, 2024 & 2034 (USD Million)